Beiersdorf reports third-quarter decline as Beiersdorf stock falls 2.14 percent
Published on 10/27/2026 at 09:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly performance splits by brand
- Beiersdorf reported a 1.3 percent organic sales decline for the third quarter on October 27, 2026.
- Derma delivered 10.6 percent organic growth in the third quarter, while NIVEA declined 4.9 percent.
- Beiersdorf stock traded at EUR 81.50 at 9:00 a.m. CET at Lang & Schwarz on October 27, 2026, 2.14 percent below the Xetra close of October 26, 2026.
Beiersdorf AG (ISIN DE0005200000) reported a 1.3 percent organic sales decline in the third quarter of 2026, while confirming its full-year guidance in a release carried by MarketScreener on October 27, 2026. The mixed brand performance puts the NIVEA turnaround at the center of the stock story.
Growth remains concentrated
Group net sales reached EUR 2.4 billion in the third quarter, while sales for the first nine months totaled EUR 7.3 billion, down 2.8 percent organically, according to MarketScreener. Derma, led by Eucerin and Aquaphor, grew 10.6 percent organically in the quarter, showing where Beiersdorf is currently generating momentum.
La Prairie added 8.5 percent organically, while Health Care grew 5.7 percent. NIVEA moved in the opposite direction, with organic sales down 4.9 percent in the third quarter, although the company said its sales dynamics improved from the second quarter.
What does guidance imply?
Beiersdorf kept its forecast for a low-single-digit organic sales decline at group level and an EBIT margin excluding special factors of at least 11.8 percent for 2026, as MarketScreener reported from the company release. Consumer guidance calls for an EBIT margin of at least 11.0 percent. For tesa, semiconductor shortages reduced Electronics sales by 4.3 percent organically and could weigh further on full-year profitability.
Stock reflects the weak mix
At Lang & Schwarz, Beiersdorf stock traded at EUR 81.50 on October 27, 2026 at 9:00 a.m. CET. That was EUR 1.78, or 2.14 percent, below the Xetra close of October 26, 2026 at EUR 83.28. The quote was in the regular Xetra trading phase, making the market reaction more relevant than a pre-market indication.
The stock remained inside its EUR 67.08 to EUR 110.20 52-week range, while the market capitalization stood at EUR 17.8 billion as of October 27, 2026. The immediate investor question is whether improving Derma growth can offset continued pressure on NIVEA and the tesa Electronics business.
The further course of trading is shown by the continuously updated real-time quote of Beiersdorf stock.
Beiersdorf stock facts
- Company: Beiersdorf AG
- ISIN: DE0005200000
- Ticker: BEI.DE
- Price Lang & Schwarz (as of October 27, 2026, 9:00 a.m. CET): EUR 81.50
- Change versus Xetra close: minus 2.14 percent
- Xetra close (October 26, 2026): EUR 83.28
- Market capitalization: EUR 17.8 billion (as of October 27, 2026)
- 52-week range: EUR 67.08-EUR 110.20 (as of October 27, 2026)
Market context: Market report DAX.
